2 completed, 1 recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Coproporphyria: new trials by email Literature Review of Coproporphyria trials Research Report on Coproporphyria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) Acute Hepatic Porphyria | Completed | Alnylam Pharmaceuticals | 136 | 2014-08-01 | 2021-05-17 | |
| Longitudinal Study of the Porphyrias Acute Porphyrias, Cutaneous Porphyrias | Recruiting | The American Porphyrias Expert Collaborative | 1500 | 2010-11-01 | 2026-05-15 | |
| A Randomized Study of Sulindac in Oral Premalignant Lesions sulindac, Placebo - Leukoplakia, Oral, Benign Neoplasms | Not applicable | Completed | Memorial Sloan Kettering Cancer Center | 63 | 2006-02-23 | 2020-11-19 |
Porphyrias (2) · Coproporphyria, Hereditary (1) · Leukoplakia, Oral (1) · Neoplasms (1) · Porphyria, Acute Intermittent (1) · Protoporphyria, Erythropoietic (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Genetic Diseases, Inborn (2) · Liver Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Porphyrias, Hepatic (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Head and Neck Neoplasms (1) · Leukoplakia (1) · Mouth Diseases (1) · Mouth Neoplasms (1) · Neoplasms by Site (1)
Sulindac (1)
Alnylam Pharmaceuticals (1) · Memorial Sloan Kettering Cancer Center (1) · The American Porphyrias Expert Collaborative (1)
United States (3) · Australia (1) · Belgium (1) · Bulgaria (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Mexico (1) · Netherlands (1) · Norway (1) · Poland (1)
Hetanshi Naik, PhD (1) · Jay O. Boyle, M.D. (1)
PMID 25016127, PMID 28614581, PMID 32681675, PMID 39969427
U54DK083909 (1)